Variables | No. of patients | Median survival (months) | p value |
---|---|---|---|
Age (years) | Â | Â | NS |
   >60 | 7 | 38 |  |
   ≤60 | 30 | 63 |  |
Gender | Â | Â | NS |
   Male | 32 | 50 |  |
   Female | 5 | 65 |  |
Serum AFP (ng/mL) | Â | Â | NS |
   >100 | 13 | 50 |  |
   ≤100 | 24 | 59 |  |
Serum total bilirubin (umol/L) | Â | Â | NS |
   >20 | 8 | 35 |  |
   ≤20 | 29 | 63 |  |
Serum ALT (IU/L) | Â | Â | NS |
   >40 | 12 | 37 |  |
   ≤40 | 25 | 59 |  |
Serum AST (IU/L) | Â | Â | NS |
   >40 | 7 | 48 |  |
   ≤40 | 30 | 59 |  |
Background liver tissue | Â | Â | NS |
   Non-cirrhotic | 17 | 64 |  |
   Cirrhotic | 20 | 44 |  |
Tumors capsule formation | Â | Â | NS |
   Absent | 11 | 48 |  |
   Present | 26 | 64 |  |
Tumors size (cm) | Â | Â | NS |
   >3 | 15 | 50 |  |
   ≤3 | 22 | 59 |  |
Number of tumors | Â | Â | 0.040 |
   Solitary | 28 | 64 |  |
   Multiple | 9 | 37 |  |
Vascular invasion | Â | Â | 0.004 |
   Absent | 18 | 68 |  |
   Present | 19 | 38 |  |
Edmonson-Steiner grade | Â | Â | NS |
   G1-G2 | 4 | 50 |  |
   G3-G4 | 33 | 59 |  |
Recurrence-free interval (year) | Â | Â | <0.001 |
   >1 | 29 | 64 |  |
   ≤1 | 8 | 29 |  |